key: cord-0909919-2eisler0 authors: Chhikara, Komal; Kanta, Poonam; Ghosh, Arnab; Prakash, Rishi Chetanya; Goyal, Kapil; Singh, Mini P title: Validation of SARS CoV-2 detection by real time PCR in matched pooled and deconvoluted clinical samples before and after nucleic acid extraction: A study in tertiary care hospital of North India date: 2020-09-12 journal: Diagn Microbiol Infect Dis DOI: 10.1016/j.diagmicrobio.2020.115206 sha: 9a5846bc7e83df51e77720b5451fd661f4df15a7 doc_id: 909919 cord_uid: 2eisler0 The diagnosis of COVID-19 diseases relies on the detection of SARS CoV-2 RNA by real time RT-PCR in respiratory samples. Rapid increase in the COVID-19 cases across the world requires fast and efficient testing as testing capacity is a bottleneck in diagnosis. In this context, pooling strategy can be opted for rapid testing in a cost-effective manner. In this study the authors have optimized and compared the effect of pooling (5 & 10 samples) before and after nucleic acid extraction. It was concluded that there was no significant difference in the SARS CoV-2 RNA detection in the pools prepared at sample or RNA level. Even after pooling, 10-fold dilution was detectable with 3 Ct value change in both type of pools when compared with individual samples. Hence, sample pool size of 10 can be used in low prevalent areas and testing capacity can be substantially increased. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) which originated in the Wuhan city of China spreading across 215 countries and affecting more than 7.2 million people worldwide and cases are still increasing further (https://www.worldometers.info/coronavirus/). Human to human transmission occurs mainly through respiratory droplets (while coughing & sneezing), however possible transmission through aerosol route and faeco oral route has also been postulated (Chen et al., 2020) . There is also evidence of presence of virus in the saliva and breast milk which may also be a possible source of transmission (Azzi et al., 2020; Groß et al., 2020) . It has been seen that persons who are pre symptomatic or asymptomatic can also transmit the virus. The gold standard for the laboratory diagnosis of SARS CoV-2 is Reverse transcription-real-time PCR panel (rRT-PCR) recommended by Centre for Disease Control and Prevention (CDC), Atlanta due to its high sensitivity and specificity which is carried out in throat/nasopharyngeal swabs. There is emphasis to increase the testing capacity so as to identify the infectious cases and quarantine them thereby preventing the transmission to their contacts. This testing is a constraint in terms of limitations of reagents and cost of testing specially in resource limited developing countries. In such scenarios, pool testing is beneficial for screening purposes, contact tracing, and population-based studies where the positivity of SARS CoV-2 is likely to be less than <2% (Chandrashekar, 2014) . The size of the pool depends upon the type of virus and prevalence in the country but each positive pool needs to be deconvoluted individually. The current study focused on the standardization and validation of pool testing before and after nucleic acid extraction for the diagnosis of SARS CoV-2. The initial standardization was carried out by performing the Reverse transcription-real-time PCR (rRT-PCR) in two mini pools (size of 5&10) prepared before and after nucleic acid extraction which was further validated in a large number of pools. The study would be beneficial in policy making to increase the testing capacity with low budget in low COVID-19 prevalent areas and in asymptomatic individuals and populationbased studies. The study was carried out in the Department of Virology in a tertiary care hospital in North India. The department has a dedicated BSL class II facility and the testing for SARS CoV-2 was carried out as per ICMR testing guidelines. The throat swabs (TS)/ nasopharyngeal swabs (NS) collected in viral transport medium (VTM) and received in cold chain from suspected COVID 19 patients were used for the study. These samples had been stored in aliquots in -J o u r n a l P r e -p r o o f Journal Pre-proof 80℃ subsequent to initial diagnostic testing and no additional sampling was performed for the study purpose. The study was approved by Institute Ethical Committee (IEC). The nucleic acid extraction of samples and pools was performed using NucliSens TM -easyMAG (Biomeurix, France) or Qiagen viral mini kit (Qiagen, Germany) according to manufacturer's protocol. The elution was done in 60 µl of elution buffer and RNA was stored at 4℃ and used the same day for real time PCR. Samples: A total of 500 samples were consecutively pooled in groups of 5 (Total 100 pools-11 positive pools and 89 negative pools) as per ICMR guidelines of pooling 5 samples (https://www.mohfw.gov.in/pdf/letterregguidanceonpoolingsamplesfortesting001.pdf). All the positive pools and 5% of the negative pools was deconvoluted and tested individually. The 5 µl RNA of positive pools (pool of 5 sample) was again diluted with 20 µl of nuclease free water to get a dilution of 10 which was further used for the detection of SARS CoV-2 genes. The 5% negative pools with Ct value above kit cutoff (>37) of N, ORF-1ab and S gene were subjected to deconvolution and none of the genes was found to be positive for SARS CoV-2. Our data had demonstrated that the individual sample with high Ct value could be efficiently detected in both pools (pool of 5 or pool of 10) prepared before (at sample level) and after nucleic acid extractions (at RNA level). In contrast to Van As expected, it has been observed that the 500 asymptomatic blinded clinical samples were efficiently tested by adopting a pooling strategy (5 blinded sequential samples) for the presence of SARS CoV-2. These positive pools (11%), n=11/100) were tested individually and found that the Ct values are not affected due to presence of more than one positive sample in a single pool. Pool testing should be done in a small pool size as it is easy to screen out negative samples in small pools compared to large pools. It will be easy to deconvolute the positive pool in less turnaround time and repeat testing will be fast if the pool size is small. To our knowledge, our study is unique in that aspect that we had looked into the effect of pooling samples on multiple genes namely N, ORF-1ab and S gene of SARS CoV-2. Pooling even in the ratio 1:9 did not affect the detection of samples in terms of N and ORF-1ab genes. Thus, kits involving these 2 genes may be useful in diagnosing SARS CoV-2 in pooled samples without any effect of dilution. However, validating such kits will require studies with larger sample size. CDC, Atlanta has recommended various kits for the detection of SARS CoV-2 RNA. In the present study, a single tube assay was used for the detection of SARS CoV-2 genes. However, in different public health laboratories different COVID testing kits (each with different panels combinations) are available and the sensitivity might suffer in pool testing but kits with single tube assay targeting multiple genes will be useful for reducing resources and increasing sensitivity in pool samples. In conclusion, emphasize that TS/NS can be pooled in a pool of 10 without scarifying the sensitivity of SARS CoV-2 testing. Moreover, pooling of 10 samples before J o u r n a l P r e -p r o o f Journal Pre-proof nucleic acid extraction will increase the testing capacity with minimum resources in the pandemic era of infectious diseases in areas with low prevalence. Uniqueness-In this study we have targeted 3 genes using multiplex single tube testing and found more consistent results with N gene as the screening gene and ORF-1ab as the confirmatory gene in contrast to S gene. Another important aspect of the study is investigating pooled and deconvoluted clinical samples before and after nucleic acid extraction. Saliva is a reliable tool to detect SARS-CoV-2 Half a decade of mini-pool nucleic acid testing: Cost-effective way for improving blood safety in India. Asian journal of transfusion science The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients Detection of SARS-CoV-2 in human breastmilk. The Lancet Sample pooling as a strategy to detect community transmission of SARS-CoV-2 Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus To pool or not to pool? Guidelines for pooling samples for use in surveillance testing of infectious diseases in aquatic animals Rapid, large-scale, and effective detection of COVID-19 via nonadaptive testing. bioRxiv Pooling nasopharyngeal/throat swab specimens to increase testing capacity for influenza viruses by PCR Evaluation of COVID-19 RT-qPCR test in multi-sample pools. medRxiv Predictive model for Zika virus RNA minipool nucleic acid testing in outbreak scenarios This work was carried out under the activity of Regional VRDL at PGIMER, Chandigarh. The support from ICMR is duly acknowledged.Funding: This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.